Global burden of vaccine‐associated anaphylaxis and their related vaccines, 1967–2023: A comprehensive analysis of the international pharmacovigilance database
Allergy2023Vol. 79(3), pp. 690–701
Citations Over TimeTop 10% of 2023 papers
K. K. Lee, Hayeon Lee, Rosie Kwon, Youn Ho Shin, Seung Geun Yeo, Young Ju Lee, Min Seo Kim, Yong‐Sung Choi, Nikolaos G. Papadopoulos, Masoud Rahmati, Junyang Jung, Jinseok Lee, Dong Keon Yon
Abstract
Although multiple vaccines are associated with various spectra and risks of anaphylaxis, clinicians should recognize the possibility of anaphylaxis occurring with all vaccines, particularly the COVID-19 mRNA and inactivated whole-virus COVID-19 vaccines, and consider the risk factors associated with vaccine anaphylaxis reports. Further studies are warranted to identify better ways of preventing vaccine-associated anaphylaxis.
Related Papers
- → Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial(1999)174 cited
- → Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community(2008)22 cited
- → Interchangeability of Hepatitis A boosters, Avaxim® and Vaqta®, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim®(2006)5 cited
- Research on Control of the Outbreak of Hepatitis A Using Inactivated Hepatitis A Vaccine(2007)
- Result of Boosting of Inactivated Hepatitis A Vaccine Healive(2003)